BioSpace News Archive

Policy

Lawsuits Allege Safety Concern Over Novartis CML Drug Tasigna

A Novartis leukemia drug continues to be the subject of a handful of lawsuits filed by plaintiffs due to concerns over atherosclerosis-related conditions.

March 29, 2018
·
2 min read
·
Alex Keown
Business

MediciNova’s Drug Flunks Phase II Trial

MediciNova announced that its Phase II clinical trial of ibudilast (MN-166) failed to meet its primary endpoint for methamphetamine dependence.

March 29, 2018
·
2 min read
·
Mark Terry
Drug Development

Heron Seeks Sale of Common Stock to Fund Potential Drug Launch

Heron Therapeutics is looking to raise money to fund a potential launch of its anesthetic for bunionectomy and hernia repair by selling six million shares of its common stock.

March 29, 2018
·
2 min read
·
Alex Keown
Drug Development

RedX Pharma Cancer Trial Paused: Serious Side Effects

Redx Pharma dosed its first patient for the Porcupine inhibitor RXC004 on February 6. The company indicates it has paused the trial after the first patient dosed had “clinically significant” adverse events.

March 29, 2018
·
2 min read
·
Mark Terry
Trend Alert: Pharma Increases Funding for Outside Innovation

According to HBM Partners, a healthcare investing firm, out of the drugs approved over the last five years, 63 percent originated at smaller companies.

March 29, 2018
·
3 min read
·
Mark Terry